The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all‐cause mortality in patients who undergo noncardiac surgery
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"The Comparative and Added Prognostic Value of Biomarkers to the Revised Cardiac Risk Index for Preoperative Prediction of Major Adverse Cardiac Events and All‐cause Mortality in Patients Who Undergo Noncardiac Surgery." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440249/all/The_comparative_and_added_prognostic_value_of_biomarkers_to_the_Revised_Cardiac_Risk_Index_for_preoperative_prediction_of_major_adverse_cardiac_events_and_all‐cause_mortality_in_patients_who_undergo_noncardiac_surgery.
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all‐cause mortality in patients who undergo noncardiac surgery. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440249/all/The_comparative_and_added_prognostic_value_of_biomarkers_to_the_Revised_Cardiac_Risk_Index_for_preoperative_prediction_of_major_adverse_cardiac_events_and_all‐cause_mortality_in_patients_who_undergo_noncardiac_surgery. Accessed February 9, 2025.
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all‐cause mortality in patients who undergo noncardiac surgery. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440249/all/The_comparative_and_added_prognostic_value_of_biomarkers_to_the_Revised_Cardiac_Risk_Index_for_preoperative_prediction_of_major_adverse_cardiac_events_and_all‐cause_mortality_in_patients_who_undergo_noncardiac_surgery
The Comparative and Added Prognostic Value of Biomarkers to the Revised Cardiac Risk Index for Preoperative Prediction of Major Adverse Cardiac Events and All‐cause Mortality in Patients Who Undergo Noncardiac Surgery [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440249/all/The_comparative_and_added_prognostic_value_of_biomarkers_to_the_Revised_Cardiac_Risk_Index_for_preoperative_prediction_of_major_adverse_cardiac_events_and_all‐cause_mortality_in_patients_who_undergo_noncardiac_surgery.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all‐cause mortality in patients who undergo noncardiac surgery
ID - 440249
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440249/all/The_comparative_and_added_prognostic_value_of_biomarkers_to_the_Revised_Cardiac_Risk_Index_for_preoperative_prediction_of_major_adverse_cardiac_events_and_all‐cause_mortality_in_patients_who_undergo_noncardiac_surgery
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -